Company Filing History:
Years Active: 2006
Title: Innovations of Chinnapillai Rajendran in Pharmaceutical Chemistry
Introduction
Chinnapillai Rajendran is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes in drug preparation. His work is characterized by a focus on reducing impurities in pharmaceutical compounds, which is crucial for the efficacy and safety of medications.
Latest Patents
Rajendran holds a patent for a process titled "Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran carbonitrile." This invention provides a method for preparing crude 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran carbonitrile base with substantially low levels of impurities. The process effectively arrests the formation of carboxamide impurities and high molecular weight impurities while suppressing the formation of desmethylcitalopram. This innovative approach allows for the cyanide exchange reaction to reach near completion, thereby avoiding extensive and costly purification processes.
Career Highlights
Chinnapillai Rajendran is currently associated with Sun Pharmaceutical Industries Limited, a leading global pharmaceutical company. His role in the company has allowed him to apply his expertise in drug formulation and development, contributing to the advancement of pharmaceutical sciences.
Collaborations
Rajendran has collaborated with notable colleagues such as Thennati Rajamannar and Kilaru Srinivasu. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Chinnapillai Rajendran's contributions to pharmaceutical chemistry through his innovative patent demonstrate his commitment to improving drug preparation processes. His work not only enhances the quality of pharmaceutical products but also reflects the importance of innovation in the healthcare industry.